The United Kingdom is experiencing a growing interest in copyright substances , particularly N,N-Dimethyltryptamine and this lesser-known cannabinoid. Researchers are steadily studying the applications of these substances for therapeutic purposes, leading a complex discussion around their ethical position and safe application . Despite prohibitions